Patents by Inventor Robert E. Bird
Robert E. Bird has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6515110Abstract: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.Type: GrantFiled: November 19, 1999Date of Patent: February 4, 2003Assignee: Enzon, Inc.Inventors: Marc D. Whitlow, James F. Wood, Karl D. Hardman, Robert E. Bird, David Filpula, Michele Rollence
-
Patent number: 6121424Abstract: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.Type: GrantFiled: October 5, 1998Date of Patent: September 19, 2000Assignee: Enzon, Inc.Inventors: Marc D. Whitlow, James F. Wood, Karl D. Hardman, Robert E. Bird, David Filpula, Michele Rollence
-
Patent number: 6103889Abstract: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.Type: GrantFiled: October 14, 1998Date of Patent: August 15, 2000Assignee: Enzon, Inc.Inventors: Marc D. Whitlow, Karl D. Hardman, Robert E. Bird, David Filpula
-
Patent number: 6027725Abstract: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.Type: GrantFiled: October 5, 1998Date of Patent: February 22, 2000Assignee: Enzon, Inc.Inventors: Marc D. Whitlow, James F. Wood, Karl D. Hardman, Robert E. Bird, David Filpula, Michele Rollence
-
Patent number: 6025165Abstract: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.Type: GrantFiled: October 5, 1998Date of Patent: February 15, 2000Assignee: Enzon, Inc.Inventors: Marc D. Whitlow, James F. Wood, Karl D. Hardman, Robert E. Bird, David Filpula, Michele Rollence
-
Patent number: 5869620Abstract: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.Type: GrantFiled: February 22, 1995Date of Patent: February 9, 1999Assignee: Enzon, Inc.Inventors: Marc D. Whitlow, James F. Wood, Karl D. Hardman, Robert E. Bird, David Filpula, Michele Rollence
-
Patent number: 5817457Abstract: Improved assay for the detection of viral reverse transcriptase activity using PCR conducts the reverse transcription reaction at an acidic pH or elevated temperature. The assay is useful in testing a wide variety of biological products and tissue samples.Type: GrantFiled: February 7, 1996Date of Patent: October 6, 1998Assignee: MA BioServices, Inc.Inventors: Robert E. Bird, Audrey Chang-Yeh
-
Patent number: 5587458Abstract: The present invention relates to novel antibodies, in particular monoclonal and single chain antibodies derived therefrom which specifically bind to erbB-2, as well as diagnostic and therapeutic uses thereof. The present invention also relates to a combination of at least two erbB-2 specific antibodies which are capable of preventing and treating human malignancies wherein the malignant cells overexpress gp185.sup.erbB-2. The monoclonal antibodies of the combination preferably recognize different epitopes of the gp185 expression product of erbB-2, therefore, the antibodies do not cross react with each other. Preferably, the combination will provide for synergistic decrease in the expression of the erbB-2 gene product.Type: GrantFiled: May 14, 1993Date of Patent: December 24, 1996Assignee: Aronex Pharmaceuticals, Inc.Inventors: C. Richter King, Philip G. Kasprzyk, Robert E. Bird
-
Patent number: 5534621Abstract: The invention pertains to a single polypeptide chain binding molecule which has binding specificity and affinity substantially similar to the binding specificity and affinity of the light and heavy chain aggregate variable region of an antibody, to genetic sequences coding therefor, and to recombinant DNA methods of producing such molecule and uses for such molecule.Type: GrantFiled: June 6, 1995Date of Patent: July 9, 1996Assignee: Enzon Labs, Inc.Inventors: Robert C. Ladner, Robert E. Bird, Karl Hardman
-
Patent number: 5518889Abstract: The invention pertains to a single polypeptide chain binding molecule which has binding specificity and affinity substantially similar to the binding specificity and affinity of the light and heavy chain aggregate variable region of an antibody, to genetic sequences coding therefor, and to recombinant DNA methods of producing such molecule and uses for such molecule.Type: GrantFiled: June 6, 1995Date of Patent: May 21, 1996Assignee: Enzon Labs Inc.Inventors: Robert C. Ladner, Robert E. Bird, Karl Hardman
-
Patent number: 5455030Abstract: The invention pertains to a single polypeptide chain binding molecule which has binding specificity and affinity substantially similar to the binding specificity and affinity of the light and heavy chain aggregate variable region of an antibody, to genetic sequences coding therefor, and to recombinant DNA methods of producing such molecule and uses for such molecule.Type: GrantFiled: April 1, 1993Date of Patent: October 3, 1995Assignee: Enzon Labs, Inc.Inventors: Robert C. Ladner, Robert E. Bird, Karl Hardman
-
Patent number: 5260203Abstract: The invention pertains to a single polypeptide chain binding molecule which has binding specificity and affinity substantially similar to the binding specificity and affinity of the light and heavy chain aggregate variable region of an antibody, to genetic sequences coding therefor, and to recombinant DNA methods of producing such molecule and uses for such molecule.Type: GrantFiled: April 25, 1990Date of Patent: November 9, 1993Assignee: Enzon, Inc.Inventors: Robert C. Ladner, Robert E. Bird, Karl Hardman
-
Patent number: 5022442Abstract: An apparatus and method for high pressure gas filling of gas cylinders is disclosed. The apparatus includes an elongated filling tube for a pressurized gas cylinder having a valve regulator/fitting sealed in an opening at one end of the gas cylinder, the elongated filling tube extending within the cylinder and being attached at one end to the valve regulator/fitting. The elongated filling tube is provided with longitudinally spaced transverse openings along the length thereof to facilitate intermixing of gases injected into the cylinder under pressure.Type: GrantFiled: March 20, 1989Date of Patent: June 11, 1991Assignee: Acetylene Gas CompanyInventor: Robert E. Bird
-
Patent number: 4946778Abstract: The invention pertains to a single polypeptide chain binding molecule which has binding specificity and affinity substantially similar to the binding specificity and affinity of the light and heavy chain aggregate variable region of an antibody, to genetic sequences coding therefor, and to recombinant DNA methods of producing such molecule and uses for such molecule.Type: GrantFiled: January 19, 1989Date of Patent: August 7, 1990Assignee: Genex CorporationInventors: Robert C. Ladner, Robert E. Bird, Karl Hardman
-
Patent number: 4319604Abstract: In a safety shut-off valve, a housing includes a valve member therein, having a first valve seat, and against which a valve normally rests during closure, with a spring normally biasing said valve off of said first valve seat, and with the force of the pressurized fluid passing through the valve causing said valve to act against the force of a regulator and a second spring to become unseated for allowing gas flow, and reseated once again against a second valve seat when excessive pressure is encountered and which curtails the further flow of fluid through the valve housing, and thereby shutting off the fluid from its source.Type: GrantFiled: February 19, 1980Date of Patent: March 16, 1982Assignee: Modern Engineering Company, Inc.Inventor: Robert E. Bird
-
Patent number: 4263939Abstract: In a single stage regulator as used in conjunction with a high pressure vessel, a surge reducing valve is positioned within the outlet from the regulator and just at its low pressure side of the regulator in order to reduce any surge or jump in the gas flow during sustained gas consumption or when it is shut off.Type: GrantFiled: April 27, 1979Date of Patent: April 28, 1981Assignee: Modern Engineering Company, Inc.Inventor: Robert E. Bird